search
Back to results

Virtual Imaging-based Early Portal Pressure Gradient (vePPG) (CHESS1702) (vePPG)

Primary Purpose

Hypertension, Portal

Status
Withdrawn
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Invasive PPG
Sponsored by
Nanfang Hospital, Southern Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Hypertension, Portal focused on measuring Portal pressure gradient, Transjugular intrahepatic portosystemic shunt, Virtual imaging-based portal pressure gradient

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients providing written informed consent
  • Patients with portal hypertension and received the placement of TIPS
  • Patients with invasive immediate PPG and early PPG measurement
  • Has undergone > 64 multi-detector row CT angiography and Doppler ultrasound within 3 days prior to invasive early PPG measurement

Exclusion Criteria:

  • Any severe adverse events after TIPS placement
  • Inability to adhere to study procedures
  • Prior devascularization operation
  • Has received a liver transplant
  • Patients with known anaphylactic allergy to iodinated contrast
  • Pregnancy or unknown pregnancy status
  • Patient requires an emergent procedure
  • Any active, serious, life-threatening disease

Sites / Locations

  • 302 Hospital of PLA
  • Beijing Ditan Hospital, Capital Medical University
  • Beijing Shijitan Hospital, Capital Medical University
  • PLA Army General Hospital
  • Nanfang Hospital, Southern Medical University
  • The First Affiliated Hospital of Sun Yat-sen University
  • The Third Affiliated Hospital of Sun Yat-Sen University
  • Xingtai People's Hospital
  • The Third Xiangya Hospital of Central South University
  • Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Single arm study

Arm Description

Patients will receive CT angiography, Doppler ultrasound, invasive PPG, and vePPG per protocol. Intervention: Procedure: Invasive PPG

Outcomes

Primary Outcome Measures

vePPG Numerical Correlation
Correlation of vePPG numerical value with early PPG numerical value

Secondary Outcome Measures

Immediate PPG Numerical Correlation
Correlation of immediate PPG numerical value with early PPG numerical value
Diagnostic Performance of vePPG
Accuracy, sensitivity, specificity, positive predictive value and negative predictive value of vePPG to determine re-intervention or not when compared to invasive early PPG as reference (PPG≥12mmHg)

Full Information

First Posted
June 4, 2017
Last Updated
January 4, 2019
Sponsor
Nanfang Hospital, Southern Medical University
Collaborators
Beijing Shijitan Hospital, Capital Medical University, Beijing 302 Hospital, The Third Xiangya Hospital of Central South University, Xingtai People's Hospital, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, First Affiliated Hospital, Sun Yat-Sen University, Beijing Ditan Hospital, PLA Army General Hospital, Third Affiliated Hospital, Sun Yat-Sen University
search

1. Study Identification

Unique Protocol Identification Number
NCT03177499
Brief Title
Virtual Imaging-based Early Portal Pressure Gradient (vePPG) (CHESS1702)
Acronym
vePPG
Official Title
Virtual Imaging-based Early Portal Pressure Gradient (vePPG) After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Withdrawn
Why Stopped
No participants enrolled
Study Start Date
August 24, 2017 (Actual)
Primary Completion Date
January 2019 (Anticipated)
Study Completion Date
January 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Nanfang Hospital, Southern Medical University
Collaborators
Beijing Shijitan Hospital, Capital Medical University, Beijing 302 Hospital, The Third Xiangya Hospital of Central South University, Xingtai People's Hospital, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, First Affiliated Hospital, Sun Yat-Sen University, Beijing Ditan Hospital, PLA Army General Hospital, Third Affiliated Hospital, Sun Yat-Sen University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Portal pressure gradient (PPG) above 12 mmHg after transjugular intrahepatic portosystemic shunt (TIPS) increases the risk of portal hypertension complications. Currently, a PPG reduction <12 mmHg after TIPS is the most consistent threshold associated with almost complete protection from variceal bleeding and ascites. However, the measurement of PPG requires an invasive procedure. A recent study investigated the variations in PPG measurements collected at different time points after placement of TIPS and demonstrated that a time point of at least 24 hours after which PPG values were best maintained (early PPG). It is of great clinical value to propose that an immediate PPG measurement fail to accurately identify the risk of decompensated event. And early PPG would change the decision making for re-intervention or not. However, the repeated invasive examination is extremely difficult to follow in clinical practice worldwide. The prospective multicenter trial aims to assess the diagnostic performance of a virtual imaging-based early portal pressure gradient (vePPG) (investigational technology) from CT angiography and Doppler ultrasound with invasive early PPG measurement as reference. The study participants with portal hypertension will be prospectively recruited at 10 high-volume liver centers in China.
Detailed Description
Portal pressure gradient (PPG) above 12 mmHg after transjugular intrahepatic portosystemic shunt (TIPS) increases the risk of portal hypertension complications. Currently, a PPG reduction <12 mmHg after TIPS is the most consistent threshold associated with almost complete protection from variceal bleeding and ascites. However, the measurement of PPG requires an invasive procedure. A recent study investigated the variations in PPG measurements collected at different time points after placement of TIPS and demonstrated that a time point of at least 24 hours after which PPG values were best maintained (early PPG). It is of great clinical value to propose that an immediate PPG measurement fail to accurately identify the risk of decompensated event. And early PPG would change the decision making for re-intervention or not. However, the repeated invasive examination is extremely difficult to follow in clinical practice worldwide. The prospective multicenter trial aims to assess the diagnostic performance of a virtual imaging-based early portal pressure gradient (vePPG) (investigational technology) from CT angiography and Doppler ultrasound with invasive early PPG measurement as reference. The study participants with portal hypertension will be prospectively recruited at 10 high-volume liver centers (Beijing Shijitan Hospital; 302 Hospital of PLA; Nanfang Hospital, Southern Medical University; The Third Xiangya Hospital of Central South University; Xingtai People's Hospital; Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University; First Affiliated Hospital, Sun Yat-Sen University; Beijing Ditan Hospital; PLA Army General Hospital; Third Affiliated Hospital, Sun Yat-Sen University) in China.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension, Portal
Keywords
Portal pressure gradient, Transjugular intrahepatic portosystemic shunt, Virtual imaging-based portal pressure gradient

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Single arm study
Arm Type
Experimental
Arm Description
Patients will receive CT angiography, Doppler ultrasound, invasive PPG, and vePPG per protocol. Intervention: Procedure: Invasive PPG
Intervention Type
Procedure
Intervention Name(s)
Invasive PPG
Intervention Description
Invasive PPG obtained by means of catheterization.
Primary Outcome Measure Information:
Title
vePPG Numerical Correlation
Description
Correlation of vePPG numerical value with early PPG numerical value
Time Frame
1 day
Secondary Outcome Measure Information:
Title
Immediate PPG Numerical Correlation
Description
Correlation of immediate PPG numerical value with early PPG numerical value
Time Frame
7 days
Title
Diagnostic Performance of vePPG
Description
Accuracy, sensitivity, specificity, positive predictive value and negative predictive value of vePPG to determine re-intervention or not when compared to invasive early PPG as reference (PPG≥12mmHg)
Time Frame
1 day

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients providing written informed consent Patients with portal hypertension and received the placement of TIPS Patients with invasive immediate PPG and early PPG measurement Has undergone > 64 multi-detector row CT angiography and Doppler ultrasound within 3 days prior to invasive early PPG measurement Exclusion Criteria: Any severe adverse events after TIPS placement Inability to adhere to study procedures Prior devascularization operation Has received a liver transplant Patients with known anaphylactic allergy to iodinated contrast Pregnancy or unknown pregnancy status Patient requires an emergent procedure Any active, serious, life-threatening disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fuquan Liu, MD
Organizational Affiliation
Beijing Shijitan Hospital, Capital Medical University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Zhiwei Li, MD
Organizational Affiliation
Beijing 302 Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Xiaolong Qi, MD
Organizational Affiliation
Nanfang Hospital, Southern Medical University
Official's Role
Study Chair
Facility Information:
Facility Name
302 Hospital of PLA
City
Beijing
State/Province
Beijing
Country
China
Facility Name
Beijing Ditan Hospital, Capital Medical University
City
Beijing
State/Province
Beijing
Country
China
Facility Name
Beijing Shijitan Hospital, Capital Medical University
City
Beijing
State/Province
Beijing
Country
China
Facility Name
PLA Army General Hospital
City
Beijing
State/Province
Beijing
Country
China
Facility Name
Nanfang Hospital, Southern Medical University
City
Guangzhou
State/Province
Guangdong
Country
China
Facility Name
The First Affiliated Hospital of Sun Yat-sen University
City
Guangzhou
State/Province
Guangdong
Country
China
Facility Name
The Third Affiliated Hospital of Sun Yat-Sen University
City
Guangzhou
State/Province
Guangdong
Country
China
Facility Name
Xingtai People's Hospital
City
Xingtai
State/Province
Hebei
Country
China
Facility Name
The Third Xiangya Hospital of Central South University
City
Changsha
State/Province
Hunan
Country
China
Facility Name
Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University
City
Luzhou
State/Province
Sichuan
Country
China

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
27786365
Citation
Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017 Jan;65(1):310-335. doi: 10.1002/hep.28906. Epub 2016 Dec 1. No abstract available. Erratum In: Hepatology. 2017 Jul;66(1):304.
Results Reference
background
PubMed Identifier
26047908
Citation
de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3. No abstract available.
Results Reference
background
PubMed Identifier
28130066
Citation
Silva-Junior G, Turon F, Baiges A, Cerda E, Garcia-Criado A, Blasi A, Torres F, Hernandez-Gea V, Bosch J, Garcia-Pagan JC. Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension. Gastroenterology. 2017 May;152(6):1358-1365. doi: 10.1053/j.gastro.2017.01.011. Epub 2017 Jan 24.
Results Reference
background
PubMed Identifier
22922562
Citation
Min JK, Leipsic J, Pencina MJ, Berman DS, Koo BK, van Mieghem C, Erglis A, Lin FY, Dunning AM, Apruzzese P, Budoff MJ, Cole JH, Jaffer FA, Leon MB, Malpeso J, Mancini GB, Park SJ, Schwartz RS, Shaw LJ, Mauri L. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA. 2012 Sep 26;308(12):1237-45. doi: 10.1001/2012.jama.11274.
Results Reference
background
PubMed Identifier
25398771
Citation
Qi X, Li Z, Huang J, Zhu Y, Liu H, Zhou F, Liu C, Xiao C, Dong J, Zhao Y, Xu M, Xing S, Xu W, Yang C. Virtual portal pressure gradient from anatomic CT angiography. Gut. 2015 Jun;64(6):1004-5. doi: 10.1136/gutjnl-2014-308543. Epub 2014 Nov 14. No abstract available.
Results Reference
background

Learn more about this trial

Virtual Imaging-based Early Portal Pressure Gradient (vePPG) (CHESS1702)

We'll reach out to this number within 24 hrs